drugset / Trial / NCT00141661
A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A 10-week safety and tolerability study of a potential treatment for mild to moderate Alzheimer's disease.
Timeline
- Start
- 2005-10
- Primary completion
- 2006-06
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azeliragon | Small molecule | 10 mg | Oral |
| Subject | Azeliragon | Small molecule | 20 mg | Oral |